Sanofi S.A. sell BiotechBee
Start price
23.09.22
/
70%
€78.83
Target price
31.12.24
€65.00
Performance (%)
11.65%
End price
01.11.22
€88.01
Summary
This prediction ended on 01.11.22 with a price of €88.01. The prediction closed with a disappointing performance of 11.65%. BiotechBee has 70% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Sanofi S.A. | -2.474% | -2.474% | -1.291% |
iShares Core DAX® | -1.114% | 3.430% | 25.966% |
iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% |
iShares Nikkei 225® | 2.113% | 5.501% | 23.404% |
iShares S&P 500 | 2.038% | 5.327% | 30.881% |
According to BiotechBee what are the pros and cons of Sanofi S.A. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by BiotechBee for this prediction
In the thread Sanofi S.A. diskutieren
Sell mit Kursziel 65,0
In the thread Trading Sanofi S.A.
Sell beendet
Stopped prediction by BiotechBee for Sanofi S.A.
Sanofi S.A.
Start price
Target price
Perf. (%)
€88.01
01.11.22
01.11.22
€100.00
31.12.24
31.12.24
13.11%
05.05.23
05.05.23
Could be worthwhile Investment >10% per year